SJG-136 Terminated Phase 1 Trials for previously treated Myelodysplastic Syndromes (MDS) / primary Myelodysplastic Syndromes (MDS) / Adult Acute Myeloid Leukemia With T(16;16)(p13;q22) / Secondary Acute Myeloid Leukemia (Secondary AML, sAML) / Adult Acute Myeloid Leukemia With T(8;21)(q22;q22) / Recurrent Adult Acute Lymphoblastic Leukemia (ALL) / Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities / Recurrent Adult Acute Myeloid Leukemia / blast phase Chronic myeloid leukemia / Secondary Myelodysplastic Syndromes / Adult Acute Myeloid Leukemia With T(15;17)(q22;q12) / Relapsing Chronic Myelogenous Leukemia / Refractory Chronic Lymphocytic Leukemia (CLL) / Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Treatment

Indications	Status	Purpose	Phase
DBCOND0153828 (previously treated Myelodysplastic Syndromes (MDS)) DBCOND0153442 (primary Myelodysplastic Syndromes (MDS)) DBCOND0036072 (Adult Acute Myeloid Leukemia With T(16;16)(p13;q22)) DBCOND0041078 (Secondary Acute Myeloid Leukemia (Secondary AML, sAML)) DBCOND0036073 (Adult Acute Myeloid Leukemia With T(8;21)(q22;q22)) DBCOND0114762 (Recurrent Adult Acute Lymphoblastic Leukemia (ALL)) DBCOND0028524 (Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities) DBCOND0028883 (Recurrent Adult Acute Myeloid Leukemia) DBCOND0023499 (blast phase Chronic myeloid leukemia) DBCOND0028569 (Secondary Myelodysplastic Syndromes) DBCOND0036071 (Adult Acute Myeloid Leukemia With T(15;17)(q22;q12)) DBCOND0028987 (Relapsing Chronic Myelogenous Leukemia) DBCOND0146058 (Refractory Chronic Lymphocytic Leukemia (CLL)) DBCOND0028526 (Adult Acute Myeloid Leukemia With Inv(16)(p13;q22))	Terminated	Treatment	1

clinicaltrials.gov Identifier	Title	Drugs
NCT00301769	SJG-136 in Treating Patients With Relapsed or Refractory Acute Leukemia, Myelodysplastic Syndromes, Blastic Phase Chronic Myelogenous Leukemia, or Chronic Lymphocytic Leukemia	SJG-136 (DB11965)